Vivanza Biosciences

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue3.392.270.431.580.77
Expenses3.202.530.201.580.74
EBITDA0.28-0.160.320.100.13
EBIT0.28-0.180.320.100.13
Profit Before Tax0.18-0.270.230.010.04
Net Profit0.18-0.380.230.010.04
Financial Ratios
Operating Profit Margin8.31%-6.96%74.42%6.33%17.11%
Net Profit Margin5.34%-16.52%53.49%0.63%5.26%
Earning Per Share (Diluted)0.05-0.090.060.000.01
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.7.3
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ